2611005583
  • Open Access
  • Perspective

The Evo-Devo Basis of Age-Associated Diseases: Extending the Evolvable Soma Theory of Ageing

  • Alessandro Fontana

Received: 08 October 2026 | Revised: 02 November 2026 | Accepted: 05 November 2026 | Published: 13 November 2026

Abstract

The mechanistic and evolutionary origins of age-associated diseases remain incompletely understood. Building on the Evolvable Soma Theory of Ageing (ESTA), which conceptualises development and ageing as a continuous genetically encoded programme of epigenetic change, this work extends the framework to age-associated disease. Advanced age is the strongest risk factor for many diseases, including cardiovascular disease, cancer, neurodegenerative disorders, and metabolic syndrome. The present framework proposes that the age dependence of these conditions may partly reflect their interaction with the regulatory trajectories underlying development and ageing. In this framework, age-associated epigenetic changes may represent regulated components of a lifespan-wide developmental programme, while genetic variation, environmental influences, and stochastic processes contribute to individual disease susceptibility. Disease-associated cellular states are further conceptualised as potential attractors of gene regulatory networks influenced by these trajectories. This perspective provides a theoretical framework for considering common regulatory mechanisms underlying diverse age-associated diseases.

References 

  • 1.

    de Magalhães, J.P. An overview of contemporary theories of ageing. Nat. Cell Biol. 2025, 27, 1074–1082. https://doi.org/10.1038/s41556-025-01698-7.

  • 2.

    Hoeijmakers, J.H.J. DNA Damage, Aging, and Cancer. N. Engl. J. Med. 2009, 361, 1475–1485. https://doi.org/10.1056/nejmra0804615.

  • 3.

    Horvath, S. DNA methylation age of human tissues and cell types. Genome Biol. 2013, 14, R115. https://doi.org/10.1186/gb-2013-14-10-r115. Correction in Genome Biol. 2015, 16, 96. https://doi.org/10.1186/s13059-015-0649-6.

  • 4.

    World Health Organization. Noncommunicable Diseases: Key Facts. Available online: https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases (accessed on 28 October 2024).

  • 5.

    Fontana, A.; Kyriazis, M. How evolution makes us age: Introducing the evolvable soma theory of ageing. Biosystems 2024, 243, 105271. https://doi.org/10.1016/j.biosystems.2024.105271.

  • 6.

    Fontana, A.; Kyriazis, M. Evolvable Soma Theory of Ageing: Insights from computer simulations. Biogerontology 2025, 26, 87. https://doi.org/10.1007/s10522-025-10224-z.

  • 7.

    Fontana, A. Evolvable soma theory of ageing: Observations from the natural world. GeroScience 2026, 48, 8435–8447. https://doi.org/10.1007/s11357-026-02115-z.

  • 8.

    Lopez, E.O.; Ballard, B.D.; Jan, A. Cardiovascular Disease; StatPearls Publishing: Treasure Island, FL, USA, 2025.

  • 9.

    Sung, H.; Ferlay, J.; Siegel, R.L.; et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA A Cancer J. Clin. 2021, 71, 209–249. https://doi.org/10.3322/caac.21660.

  • 10.

    Livingston, G.; Huntley, J.; Liu, K.Y.; et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. Lancet 2024, 404, 572–628. https://doi.org/10.1016/s0140-6736(24)01296-0.

  • 11.

    Saklayen, M.G. The Global Epidemic of the Metabolic Syndrome. Curr. Hypertens. Rep. 2018, 20, 12. https://doi.org/10.1007/s11906-018-0812-z.

  • 12.

    Braun, S.; Bitton-Worms, K.; LeRoith, D. The Link between the Metabolic Syndrome and Cancer. Int. J. Biol. Sci. 2011, 7, 1003–1015. https://doi.org/10.7150/ijbs.7.1003.

  • 13.

    Machado-Fragua, M.D.; Fayosse, A.; Yerramalla, M.S.; et al. Association of Metabolic Syndrome With Incident Dementia: Role of Number and Age at Measurement of Components in a 28-Year Follow-up of the Whitehall II Cohort Study. Diabetes Care 2022, 45, 2127–2135. https://doi.org/10.2337/dc22-0206.

  • 14.

    Attia, P.; Gifford, B. Outlive: The Science and Art of Longevity; Harmony: New York, NY, USA, 2023.

  • 15.

    Lloyd-Jones, D.M.; Nam, B.H.; D’Agostino, R.B.; et al. Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: A prospective study of parents and offspring. JAMA 2004, 291, 2204–2211. https://doi.org/10.1001/jama.291.18.2204.

  • 16.

    Manolio, T.A.; Collins, F.S.; Cox, N.J.; et al. Finding the missing heritability of complex diseases. Nature 2009, 461, 747–753. https://doi.org/10.1038/nature08494.

  • 17.

    Wainschtein, P.; Zhang, Y.; Schwartzentruber, J.; et al. Estimation and mapping of the missing heritability of human phenotypes. Nature 2026, 649, 1219–1227. https://doi.org/10.1038/s41586-025-09720-6.

  • 18.

    Boyle, E.A.; Li, Y.I.; Pritchard, J.K. An Expanded View of Complex Traits: From Polygenic to Omnigenic. Cell 2017, 169, 1177–1186. https://doi.org/10.1016/j.cell.2017.05.038.

  • 19.

    Woods, T.; Palmarini, N.; Corner, L.; et al. Cities, communities and clinics can be testbeds for human exposome and aging research. Nat. Med. 2025, 31, 1066–1068. https://doi.org/10.1038/s41591-025-03519-8.

  • 20.

    North, B.J.; Sinclair, D.A. The Intersection Between Aging and Cardiovascular Disease. Circ. Res. 2012, 110, 1097–1108. https://doi.org/10.1161/circresaha.111.246876.

  • 21.

    National Cancer Institute. Cancer Statistics Review, 1975–2018. Available online: https://seer.cancer.gov/archive/csr/1975_2018/ (accessed on 31 October 2026).

  • 22.

    Kennedy, B.K.; Berger, S.L.; Brunet, A.; et al. Geroscience: Linking Aging to Chronic Disease. Cell 2014, 159, 709–713. https://doi.org/10.1016/j.cell.2014.10.039.

  • 23.

    Fontana, A. Unravelling the nexus: Towards a unified model of development, ageing, and cancer. Biosystems 2023, 231, 104966. https://doi.org/10.1016/j.biosystems.2023.104966.

  • 24.

    Rinn, J.L. lncRNAs: Linking RNA to Chromatin. Cold Spring Harb. Perspect. Biol. 2014, 6, a018614. https://doi.org/10.1101/cshperspect.a018614.

  • 25.

    Perry, R.B.T.; Ulitsky, I. The functions of long noncoding RNAs in development and stem cells. Development 2016, 143, 3882–3894. https://doi.org/10.1242/dev.140962.

  • 26.

    Jenuwein, T.; Allis, C.D. Translating the Histone Code. Science 2001, 293, 1074–1080. https://doi.org/10.1126/science.1063127.

  • 27.

    Kirkwood, T.B.L.; Austad, S.N. Why do we age? Nature 2000, 408, 233–238. https://doi.org/10.1038/35041682.

  • 28.

    Gems, D. The hyperfunction theory: An emerging paradigm for the biology of aging. Ageing Res. Rev. 2022, 74, 101557. https://doi.org/10.1016/j.arr.2021.101557.

  • 29.

    de Magalhães, J.P. Programmatic features of aging originating in development: Aging mechanisms beyond molecular damage? FASEB J. 2012, 26, 4821–4826. https://doi.org/10.1096/fj.12-210872.

  • 30.

    Goldsmith, T.C. Aging as an evolved characteristic—Weismann’s theory reconsidered. Med. Hypotheses 2004, 62, 304–308. https://doi.org/10.1016/s0306-9877(03)00337-2.

  • 31.

    Lidsky, P.V.; Andino, R. Could aging evolve as a pathogen control strategy? Trends Ecol. Evol. 2022, 37, 1046–1057. https://doi.org/10.1016/j.tree.2022.08.003.

  • 32.

    López-Otín, C.; Blasco, M.A.; Partridge, L.; et al. Hallmarks of aging: An expanding universe. Cell 2023, 186, 243–278. https://doi.org/10.1016/j.cell.2022.11.001.

  • 33.

    Yang, J.H.; Hayano, M.; Griffin, P.T.; et al. Loss of epigenetic information as a cause of mammalian aging. Cell 2023, 186, 305–326. https://doi.org/10.1016/j.cell.2022.12.027. Correction in Cell 2024, 187, 1312–1313. https://doi.org/10.1016/j.cell.2024.01.049.

  • 34.

    Slieker, R.C.; Relton, C.L.; Gaunt, T.R.; et al. Age-related DNA methylation changes are tissue-specific with ELOVL2 promoter methylation as exception. Epigenetics Chromatin 2018, 11, 25. https://doi.org/10.1186/s13072-018-0191-3.

  • 35.

    Chatsirisupachai, K.; de Magalhães, J.P. Somatic mutations in human ageing: New insights from DNA sequencing and inherited mutations. Ageing Res. Rev. 2024, 96, 102268. https://doi.org/10.1016/j.arr.2024.102268.

  • 36.

    Fontana, L.; Partridge, L.; Longo, V.D. Extending Healthy Life Span—From Yeast to Humans. Science 2010, 328, 321–326. https://doi.org/10.1126/science.1172539.

  • 37.

    Kapahi, P.; Zid, B.M.; Harper, T.; et al. Regulation of Lifespan in Drosophila by Modulation of Genes in the TOR Signaling Pathway. Curr. Biol. 2004, 14, 885–890. https://doi.org/10.1016/j.cub.2004.03.059.

  • 38.

    Khera, A.V.; Kathiresan, S. Genetics of coronary artery disease: Discovery, biology and clinical translation. Nat. Rev. Genet. 2017, 18, 331–344. https://doi.org/10.1038/nrg.2016.160.

  • 39.

    Salk, J.J.; Fox, E.J.; Loeb, L.A. Mutational Heterogeneity in Human Cancers: Origin and Consequences. Annu. Rev. Pathol. Mech. Dis. 2010, 5, 51–75. https://doi.org/10.1146/annurev-pathol-121808-102113.

  • 40.

    Lambert, J.; Ibrahim-Verbaas, C.A.; Harold, D.; et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease. Nat. Genet. 2013, 45, 1452–1458. https://doi.org/10.1038/ng.2802.

  • 41.

    Barroso, I.; McCarthy, M.I. The genetic basis of metabolic disease. Cell 2019, 177, 146–161. https://doi.org/10.1016/j.cell.2019.02.024.

  • 42.

    Shi, Y.; Zhang, H.; Huang, S.; et al. Epigenetic regulation in cardiovascular disease: Mechanisms and advances in clinical trials. Signal Transduct. Target. Ther. 2022, 7, 200. https://doi.org/10.1038/s41392-022-01055-2.

  • 43.

    Baylin, S.B.; Jones, P.A. Epigenetic Determinants of Cancer. Cold Spring Harb. Perspect. Biol. 2016, 8, a019505. https://doi.org/10.1101/cshperspect.a019505.

  • 44.

    Stoccoro, A.; Coppedè, F. Role of Epigenetics in Alzheimer’s Disease Pathogenesis. Neurodegener. Dis. Manag. 2018, 8, 181–193. https://doi.org/10.2217/nmt-2018-0004.

  • 45.

    Ling, C.; Groop, L. Epigenetics: A Molecular Link Between Environmental Factors and Type 2 Diabetes. Diabetes 2009, 58, 2718–2725. https://doi.org/10.2337/db09-1003.

  • 46.

    la Torre, A.; Lo Vecchio, F.; Greco, A. Epigenetic Mechanisms of Aging and Aging-Associated Diseases. Cells 2023, 12, 1163. https://doi.org/10.3390/cells12081163.

  • 47.

    GBD 2021 Diseases and Injuries Collaborators. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: A systematic analysis for the Global Burden of Disease Study 2021. Lancet 2024, 403, 2100–2132. https://doi.org/10.1016/S0140-6736(24)00367-2.

  • 48.

    Alzheimer’s Association. 2024 Alzheimer’s disease facts and figures. Alzheimer’s Dement. 2024, 20, 3708–3821. https://doi.org/10.1002/alz.13809.

  • 49.

    Strogatz, S.H. Nonlinear Dynamics and Chaos: With Applications to Physics, Biology, Chemistry, and Engineering, 2nd ed.; Westview Press: Boulder, CO, USA, 2015.

  • 50.

    Kauffman, S.A. Metabolic stability and epigenesis in randomly constructed genetic nets. J. Theor. Biol. 1969, 22, 437–467. https://doi.org/10.1016/0022-5193(69)90015-0.

  • 51.

    Wang, J.; Zhang, K.; Xu, L.; et al. Quantifying the Waddington landscape and biological paths for development and differentiation. Proc. Natl. Acad. Sci. USA 2011, 108, 8257–8262. https://doi.org/10.1073/pnas.1017017108.

  • 52.

    Huang, S.; Ernberg, I.T.; Kauffman, S.A. Cancer attractors: A systems view of tumors from a gene network dynamics and developmental perspective. Semin. Cell Dev. Biol. 2009, 20, 869–876. https://doi.org/10.1016/j.semcdb.2009.07.003.

  • 53.

    Huang, S.; Kauffman, S. How to escape the cancer attractor: Rationale and limitations of multi-target drugs. Semin. Cancer Biol. 2013, 23, 270–278. https://doi.org/10.1016/j.semcancer.2013.06.003.

  • 54.

    Taherian Fard, A.; Ragan, M.A. Modeling the Attractor Landscape of Disease Progression: A Network-Based Approach. Front. Genet. 2017, 8, 48. https://doi.org/10.3389/fgene.2017.00048.

  • 55.

    Franceschi, C.; Garagnani, P.; Parini, P.; et al. Inflammaging: A new immune–metabolic viewpoint for age-related diseases. Nat. Rev. Endocrinol. 2018, 14, 576–590. https://doi.org/10.1038/s41574-018-0059-4.

  • 56.

    Shahid, Z.; Kalayanamitra, R.; McClafferty, B.; et al. COVID-19 and Older Adults: What We Know. J. Am. Geriatr. Soc. 2020, 68, 926–929. https://doi.org/10.1111/jgs.16472.

  • 57.

    Scotet, V.; L’Hostis, C.; Férec, C. The Changing Epidemiology of Cystic Fibrosis: Incidence, Survival and Impact of the CFTR Gene Discovery. Genes 2020, 11, 589. https://doi.org/10.3390/genes11060589.

  • 58.

    Iorio, A.; Stonebraker, J.S.; Chambost, H.; et al. Establishing the Prevalence and Prevalence at Birth of Hemophilia in Males. Ann. Intern. Med. 2019, 171, 540–546. https://doi.org/10.7326/m19-1208.

  • 59.

    Burtner, C.R.; Kennedy, B.K. Progeria syndromes and ageing: What is the connection? Nat. Rev. Mol. Cell Biol. 2010, 11, 567–578. https://doi.org/10.1038/nrm2944.

  • 60.

    Ashley, E.A. Towards precision medicine. Nat. Rev. Genet. 2016, 17, 507–522. https://doi.org/10.1038/nrg.2016.86.

  • 61.

    Lu, A.T.; Fei, Z.; Haghani, A.; et al. Universal DNA methylation age across mammalian tissues. Nat. Aging 2023, 3, 1144–1166. https://doi.org/10.1038/s43587-023-00462-6. Correction in Nat. Aging 2023, 3, 1462. https://doi.org/10.1038/s43587-023-00499-7.

  • 62.

    Meyer, D.H.; Schumacher, B. Aging clocks based on accumulating stochastic variation. Nat. Aging 2024, 4, 871–885. https://doi.org/10.1038/s43587-024-00619-x.

Share this article:
How to Cite
Fontana, A. The Evo-Devo Basis of Age-Associated Diseases: Extending the Evolvable Soma Theory of Ageing. Ageing and Longevity Research 2026, 2 (1), 3. https://doi.org/10.53941/alr.2026.100003.
RIS
BibTex
Copyright & License
article copyright Image
Copyright (c) 2026 by the authors.
Article Metrics
21
Article Views
0
Citations